Results 181 to 190 of about 243,754 (245)

Development of a prognostic model for in-hospital mortality in idiopathic membranous nephropathy patients with Pneumocystis jirovecii pneumonia based on persistent lymphopenia. [PDF]

BMC Infect Dis
Wang Y, Liu K, Huang C, Fu M, Lou L, Zhou Y, Li S.   +6 more
europepmc   +1 more source

The efficacy and safety of ripertamab in the treatment of idiopathic membranous nephropathy: a retrospective multicenter cohort study. [PDF]

Sci Rep
Li X, Liu Y, Zhu X, Jin H, Zhang X, Wang L, Cui Y, Xu F, Wang Y, Song Y, Cui W.   +10 more
europepmc   +1 more source

Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study. [PDF]

Front Immunol
Huang J, Yang Y, Wang Y, Jiang S, Zhang Y, Zhao S, Wang S, Chen B, Liu G.   +8 more
europepmc   +1 more source

Efficacy and safety of a B-cell-driven rituximab regimen for the treatment of refractory idiopathic membranous nephropathy. [PDF]

BMC Pharmacol Toxicol
Guo K, Zhu H, Xu X, Huang L, Li H, Li X.
europepmc   +1 more source

Benzo[b]fluoranthene is involved in idiopathic membranous nephropathy by inducing podocyte injury. [PDF]

J Transl Int Med
Yin L, Tian F, Li Z, Chen W, Liu C, Zhang Y, Liu D, Liu Z.   +7 more
europepmc   +1 more source

[Risk Factors for Idiopathic Membranous Nephropathy Complicated by Acute Kidney Injury]. [PDF]

Sichuan Da Xue Xue Bao Yi Xue Ban
Cai J, Chen Y, Lai S, Shen S.
europepmc   +1 more source

Erratum: Correlation of Body Mass Index with Clinicopathologic Parameters in Patients with Idiopathic Membranous Nephropathy [Corrigendum]. [PDF]

Diabetes Metab Syndr Obes
europepmc   +1 more source

Renal arteriolosclerosis impact on clinicopathological features and outcomes of idiopathic membranous nephropathy: a retrospective cohort analysis. [PDF]

Front Med (Lausanne)
Jiang R, Li L, Yan Y, Li H, Yu R, Huang Y, Wang L.   +6 more
europepmc   +1 more source

Hemoglobin-associated <i>CALR</i> in proximal tubule cells can be used as a biomarker for idiopathic membranous nephropathy. [PDF]

Front Med (Lausanne)
Pang S, Tan Q, Xie B, Feng B, Zhou R, Liu Z, Wei H, Huang Y, Jili M, Xie Y, Li S, Zhao B, Li W, Yang R.   +13 more
europepmc   +1 more source

Clinical evaluation of strengthening spleen and draining dampness in the treatment of idiopathic membranous nephropathy: a retrospective 10-year follow-up study. [PDF]

J Tradit Chin Med
Tianxingjian KE, Wanjia C, Ling X, Yueyi D, Yiquan W, Wangyi L, Yue X, Zhenzhen LU, Hongzhi G.   +8 more
europepmc   +1 more source